ArticleiLIVER2026
Development of a hybrid deep learning-based framework for liver fibrosis classification using ultrasound images.
Article in iLIVER, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Liver fibrosis is a progressive accumulation of extracellular matrix proteins with distortion of hepatic architecture and can progress to cirrhosis or hepatocellular carcinoma. Biopsy remains the diagnostic gold standard, however, its invasive nature, sampling error, and cost limit routine use. Ultrasound imaging provides a safer, more accessible option but depends on operator expertise and subjective interpretation. Existing deep learning approaches for fibrosis assessment often rely on small datasets or perform only binary classification. This study aimed to develop a hybrid deep learning model combining ResNet50 and VGG16 for automated multi-class classification (F0-F4), enhancing diagnostic accuracy, reducing biopsy reliance, and supporting affordable, interpretable liver disease assessment. Methods: The total of 6323 ultrasound image samples with METAVIR system labels ranging from F0 to F4 was downloaded from Kaggle. After data preprocessing, 80:20 splits were made for training and testing. A hybrid model consisting of fine-tuned ResNet50 and VGG16 was used for classification of fibrosis stages. Model performance was statistically evaluated using sensitivity, specificity, and area under the ROC curve (AUC) for each fibrosis stage, averaging across classes to address imbalance. Robustness and reproducibility were assessed by calculating 95% confidence intervals (CI) for all performance metrics through bootstrap resampling. Grad-CAM was used to interpret the model's predictions. Results: The hybrid model was also successful in achieving the highest peak in testing accuracy, reaching 86.64%, compared to the other models (55.26% for ResNet50, 72.73% for VGG16). The classification was also high for the hybrid model, with the highest values for the macro AUC and weighted AUC at 96.79% and 97.79%, respectively. The highest predicted probabilities were seen for the F0 and F4 stages, which were correctly classified, with the Grad-CAM heatmaps showing high focus on the fibrotic regions. Conclusion: The hybrid model achieved good diagnostic results with high sensitivity, specificity, and confidence. The Grad-CAM images validated that the model was focusing on significant areas, as shown by the heat map, which proves that it has potential as a non-invasive, accurate, and interpretable tool for automated liver fibrosis staging using ultrasound images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.